NEW YORK (GenomeWeb News) – Quanterix today said that the US Department of Homeland Security has awarded the firm a one-year $205,155 contract to develop an assay that can detect single molecules of botulinum toxin within complex environmental samples.
The Cambridge, Mass.-based firm will work with researchers at the Botulinum Research Center at the University of Massachusetts Dartmouth to develop and validate a high-sensitivity assay capable of measuring extremely low levels of the botulinum toxin agent. The assay would be based on the firm's Single Molecule Array (SiMoA) technology.
"The detection of low copy numbers of toxins and pathogenic bacteria for both clinical and environmental applications requires highly sensitive and rapid detection technologies capable of measuring relevant targets within complex sample mixtures," David Duffy, VP of Research at Quanterix, said in a statement. "The 1,000-fold increase in sensitivity enabled by SiMoA will facilitate the direct detection of the toxins produced by active bacteria at much lower levels than is possible today."